搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The Pharma Letter
16 小时
ViiV Healthcare’s Apretude shows over 99% effectiveness in real-world studies
ViiV Healthcare, the specialist HIV company majority owned by GSK (LSE: GSK), today announced the presentation of new ...
The Pharma Letter
15 小时
Expert's optimism at ‘maturing’ of cell and gene therapy field
At the European Cell and Gene Therapy Summit 2024, confidence in the sector’s maturity and progress was evident, highlighted ...
The Pharma Letter
17 小时
"Chemo mouth" treatment Gelclair launches in USA
California-based Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration ...
The Pharma Letter
19 小时
Bold deal takes Lilly’s UK investment to £435 million
Eli Lilly has announced a strategic collaboration with UK government departments to address population health challenges, ...
The Pharma Letter
20 小时
China’s TenNor raises $41 million in series E financing
TenNor Therapeutics has raised over 300 million yuan ($41 million) in a series E round, led by AMR Action Fund, to advance ...
The Pharma Letter
20 小时
mRNA licensing deals surge 800% in value as confidence grows beyond vaccines
A staggering 800% increase in licensing agreement deal values for messenger ribonucleic acid (mRNA)-based innovator ...
The Pharma Letter
18 小时
Forbion’s largest fundraiser yet exceeds two billion euros
Netherlands-based venture capital firm Forbion has raised over €2 billion ($2.2 billion) across its newest funds, bringing ...
The Pharma Letter
18 小时
American Lung Association invests $22 million in research
The American Lung Association Research Institute has announced a $22 million investment in 2024 to fund 139 research grants ...
The Pharma Letter
21 小时
Eli Lilly announces $340 million investment in UK
Eli Lilly (NYSE: LLY) has partnered with the UK government, investing £279 million ($340 million) to address public health ...
The Pharma Letter
20 小时
Hutchmed shares boosted by lung cancer data
Chinese biopharma Hutchmed (LON: HCM) was trading 5% higher at the mid-point of London’s trading day on Wednesday. The ...
The Pharma Letter
21 小时
TRIANA and Pfizer ink molecular glues deal
TRIANA Biomedicines has entered into a strategic collaboration and licensing agreement with US pharma giant Pfizer to ...
The Pharma Letter
22 小时
FDA approves Novocure’s Optune Lua
The US Food and Drug Administration (FDA) has approved Novocure's Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈